Which option best reflects the current stance on arginine use in severe sepsis?

• A. It is universally beneficial
• B. Its use is controversial due to potential NO-related coagulation and hemodynamic effects
• C. It has no effect on immune function
• D. It always reduces infection risk

Answer: (B)

In severe sepsis, arginine sits at a crossroads because it is the substrate for nitric oxide synthase. Nitric oxide helps immune cells fight infection, but when produced in large amounts—as often happens with inducible NOS in sepsis—it causes strong vasodilation and can lead to hypotension, microcirculatory failure, and potential coagulation disturbances. Giving more arginine could fuel this NO surge, potentially worsening blood pressure and coagulation problems, even if there might be some immune benefits in other contexts. Because the benefits of arginine in this setting are not clear and can come with real hemodynamic and coagulation risks, its use is considered controversial and is not routinely recommended. The ongoing uncertainty reflects the balance between possible immune support and the risk of NO-driven instability in septic patients.